KAO JOHN E 4

What Happened

• John E. Kao, CEO of Alignment Healthcare (ALHC), sold a total of 48,899 shares in open‑market transactions on March 12, 2026. The filing reports two disposals: 45,938 shares at a reported weighted‑average price of $17.48 (proceeds $802,812) and 2,961 shares at a reported weighted‑average price of $16.99 (proceeds $50,313). Total proceeds ~ $853,125. These were sales (not purchases).

Key Details

• Transaction dates: March 12, 2026; Form 4 filed March 13, 2026 (timely filing).
• Shares sold: 45,938 @ reported $17.48 (F2) and 2,961 @ reported $16.99 (F3); combined 48,899 shares for ~$853,125.
• Price ranges: F2 notes per‑share prices for the larger block ranged $17.035–$18.03; F3 notes the smaller block ranged $16.92–$17.03. Reported prices are weighted averages; detailed breakdown available from the company/SEC on request.
• Tax withholding: F1 states these sales represent shares sold to cover tax withholding tied to RSU vesting (i.e., not a discretionary trade).
• Ownership after transaction: Not specified in the provided excerpt.
• Trust holdings: F4 indicates some securities are held by JEK Trust (John Kao is trustee).

Context

• Because the filing indicates the sales were to satisfy tax withholding on vested restricted stock units (per F1), these transactions are routine administrative sales rather than clear signals of CEO intent to reduce exposure. Weighted‑average prices and per‑share price ranges are disclosed; the reporting person has committed to provide a full per‑price breakdown on request.